The page is the record's research on the issuer — no analyst, no rating, no view.

# TScan Therapeutics, Inc. (NASDAQ: TCRX) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

TScan Therapeutics, Inc. is listed on NASDAQ under the ticker TCRX, with ISIN US89854M1018. The LEI is not on the record, because no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.

## The disclosure read

The record holds 42 filings across 23 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 12.0 days. The latest filing is dated 2026-10-26 and is of type agm_egm, 13 days before the record date of 2026-11-08. The exchange median is 6.0 days for cadence, 52 filings and 5.0 days for latency across 4359 NASDAQ issuers. The sector median is 5.5 days for cadence, 65.5 filings and 4.0 days for latency across 176 issuers in the sector. The filings by type are: 14 directors_dealings, 8 results, 6 regulatory_filing, 5 agm_egm, 5 director_change, 2 corporate_news, 1 ad_hoc and 1 halt_suspension.

## Auditor

The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

## Orderability

The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of 2026-11-04. The chapter's orderability section carries no client_categories, so the outcome cannot name its client category.

## Coverage

No research houses were found on the investor-relations pages read, and the count is 0.

## Open research

No openly published research notes were found, and the count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

7 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001783328.json (identity.jurisdiction)
- https://mcp.us-cm-kg.ai/events/NASDAQ/TCRX (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/TCRX (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/TCRX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
